Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617
- 21 May 2019
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 46 (8) , 1756-1757
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor ControlJournal of Nuclear Medicine, 2018
- Combination of 177Lu-PSMA-617 and External Radiotherapy for the Treatment of Cerebral Metastases in Patients With Castration-Resistant Metastatic Prostate CancerClinical Nuclear Medicine, 2017
- 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate CancerJournal of Nuclear Medicine, 2016
- Brain metastasis from prostate carcinomaCancer, 2003